The supernatant was collected, and the total GSH and GSSG levels were determined by GSH and GSSG Assay Kit (Beyotime, Jiangsu, China) following the manufacturer instruction

The Mechanism of GLP-1: Promoting Satiety and Fullness GLP-1 receptor agonists work through three main pathways: Delayed gastric emptying food leaves the stomach more slowly, extending the feeling of fullness after meals Appetite suppression signals are sent to the hypothalamus (the brains hunger centre), reducing cravings and overall caloric intake Insulin and glucagon regulation insulin is released in response to meals while glucagon, which raises blood glucose, is suppressed Key Benefits of GLP-1 Beyond the Weighing Scale Weight loss is often the headline, but clinical evidence points to a broader picture: Reduction in visceral (deep abdominal) fat associated with metabolic risk Improvements in blood pressure, cholesterol, and blood glucose levels Potential cardiovascular benefit in eligible patients with obesity-related heart disease Reduced food cravings the persistent mental preoccupation with eating that many patients report Results vary between individuals
& McBURNEY, M
It is not recommended to use any medication past its expiration or Beyond-Use Date
In SA-deficient NahG plants, however, the induction of NtPR-1a transcripts was delayed as it was first detectable following a 24 h SA exposure, while 48 h of both SA and OTC treatments resulted in further elevated expression of NtPR-1a ( Figure S3 )